Correlation Between HCW Biologics and Arrayit
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Arrayit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Arrayit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Arrayit, you can compare the effects of market volatilities on HCW Biologics and Arrayit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Arrayit. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Arrayit.
Diversification Opportunities for HCW Biologics and Arrayit
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between HCW and Arrayit is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Arrayit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrayit and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Arrayit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrayit has no effect on the direction of HCW Biologics i.e., HCW Biologics and Arrayit go up and down completely randomly.
Pair Corralation between HCW Biologics and Arrayit
If you would invest 43.00 in HCW Biologics on October 7, 2024 and sell it today you would earn a total of 1.00 from holding HCW Biologics or generate 2.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 97.62% |
Values | Daily Returns |
HCW Biologics vs. Arrayit
Performance |
Timeline |
HCW Biologics |
Arrayit |
HCW Biologics and Arrayit Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HCW Biologics and Arrayit
The main advantage of trading using opposite HCW Biologics and Arrayit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Arrayit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrayit will offset losses from the drop in Arrayit's long position.HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Molecular Partners AG | HCW Biologics vs. MediciNova |
Arrayit vs. JD Sports Fashion | Arrayit vs. Sphere Entertainment Co | Arrayit vs. BRP Inc | Arrayit vs. Valhi Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data |